Inhibition of FOXD3 O-GlcNAc Modification Ameliorates Spinal Cord Injury by Promoting STUB1-Mediated Ubiquitination Degradation of HMGB1
- 24 April 2025
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (9) , 11268-11285
Abstract
Spinal cord injury (SCI) is a serious complication of spinal fractures and/or dislocations, characterized by sensory and motor dysfunction in the trunk and limbs. The pathogenesis of SCI is highly complex and remains poorly understood. The role of O-GlcNAc modification and FOXD3 in SCI was studied in this study. The cell and animal models of SCI were established by H2O2 stimulation and heavy object impact method, respectively. HE and Nissl staining were used to analyze pathological changes and neuronal loss in the spinal cord tissues. The motor ability of rats was assessed by BBB score, ladder climbing, and grid climbing tests. Cell viability and apoptosis were assessed by CCK8, flow cytometry, and TUNEL staining, respectively. Co-IP assay detected O-GlcNAc modification level of FOXD3 protein. The interaction between FOXD3 and STUB1 promoter was analyzed by dual luciferase reporter gene and ChIP assays. O-GlcNAc modification level was significantly elevated in the cell and animal models of SCI. O-GlcNAc modification increased both the protein stability and expression of FOXD3. O-GlcNAc modification inhibition or FOXD3 knockdown reduced oxidative stress damage and apoptosis in H2O2-treated PC12 cells. Moreover, FOXD3 mediated transcriptional inhibition of STUB1, and STUB1 induced HMGB1 ubiquitination and degradation in PC12 cells. STUB1 knockdown or HMGB1 overexpression negated the protective effects of FOXD3 knockdown on H2O2-mediated oxidative stress damage and apoptosis in PC12 cells. Inhibiting the O-GlcNAc modification of FOXD3 alleviated oxidative stress damage and apoptosis in nerve cells to mitigate SCI by enhancing STUB1-induced HMGB1 ubiquitination degradation.Keywords
Funding Information
- National Natural Science Foundation of China (82260525)
This publication has 46 references indexed in Scilit:
- TFEB dysregulation as a driver of autophagy dysfunction in neurodegenerative disease: Molecular mechanisms, cellular processes, and emerging therapeutic opportunitiesNeurobiology of Disease, 2019
- O-GlcNAc cycling in the developing, adult and geriatric brainJournal of Bioenergetics and Biomembranes, 2018
- FOXD3 inhibits SCN2A gene transcription in intractable epilepsy cell modelsExperimental Neurology, 2018
- High-Mobility Group Box 1 (HMGB1) Is Elevated Systemically in Persons with Acute or Chronic Traumatic Spinal Cord InjuryJournal of Neurotrauma, 2017
- Current status of cell-mediated regenerative therapies for human spinal cord injuryNeuroscience Bulletin, 2014
- Neural crest stem cell multipotency requires Foxd3 to maintain neural potential and repress mesenchymal fatesDevelopment, 2011
- Brain CHIP: removing the culprits in neurodegenerative diseaseTrends in Molecular Medicine, 2007
- CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70Nature, 2006
- CHIP: a link between the chaperone and proteasome systemsCell Stress and Chaperones, 2003
- Identification of CHIP, a Novel Tetratricopeptide Repeat-Containing Protein That Interacts with Heat Shock Proteins and Negatively Regulates Chaperone FunctionsMolecular and Cellular Biology, 1999